Does PLCO EEMS have tissue samples in addition to blood and buccal cell specimens?
Recent additions to the PLCO Biorepository include tissue microarrays (TMAs) created from formalin-fixed and paraffin-embedded pathology tissues. TMAs are currently available for colon cancer, colorectal adenoma, ovarian cancer, and prostate cancer. Ideally, TMA slides should be cut close to the time of laboratory analysis to preserve antigenicity. To minimize material loss, PLCO seeks multiple proposal applications so that slides can be cut for multiple projects at once. For additional information regarding the PLCO study, PLCO biospecimens, and TMAs, please log-in to the PLCO STaRS website at www.plcostars.com. Is funding provided? PLCO biospecimens and associated data are provided upon approval of the proposal application. However, funding is not provided via the PLCO EEMS review process. What is the PLCO EEMS application process? Proposals will be accepted for the PLCO EEMS Summer review cycle between June 01, 2010 and July 15, 2010. Applications will be accepted until July 15, 201
